| Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease A Metaxas, C Thygesen, SJ Kempf, M Anzalone, R Vaitheeswaran, ... Scientific Reports 9 (1), 15758, 2019 | 28 | 2019 |
| Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease A Metaxas, M Anzalone, R Vaitheeswaran, S Petersen, AM Landau, ... Alzheimer's research & therapy 11, 1-13, 2019 | 22 | 2019 |
| The combined effects of amyloidosis and serotonin deficiency by tryptophan hydroxylase-2 knockout impacts viability of the APP/PS1 mouse model of Alzheimer’s disease CU von Linstow, J Waider, MSS Bergh, M Anzalone, C Madsen, ... Journal of Alzheimer's Disease 85 (3), 1283-1300, 2022 | 5 | 2022 |
| Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease. Sci Rep 9: 1–15 A Metaxas, C Thygesen, SJ Kempf, M Anzalone, R Vaitheeswaran, ... | 2 | 2019 |
| Tauopathy in the APPswe/PS1ΔE9 mouse model of familial Alzheimer’s disease A Metaxas, C Thygesen, SJ Kempf, M Anzalone, R Vaitheeswaran, ... bioRxiv, 405647, 2018 | 2 | 2018 |
| Tauopathy in theAPPswe/PS1ΔE9mouse model of familial Alzheimer’s disease A Metaxas, C Thygesen, SJ Kempf, M Anzalone, R Vaitheeswaran, ... | 1 | 2018 |
| An investigation of the behavioral changes induced by the conditional inactivation of 5-HT2B receptors on microglia cells M Anzalone, A Metaxas, S Pedersen, KL Lambertsen, J Mikkelsen, ... GLIA 71, E961-E962, 2023 | | 2023 |
